G. Thomas Budd, MD, on Choosing Neoadjuvant Treatment for Patients With Early Breast Cancer

Posted: Monday, November 27, 2017

In your community, practice, or institution, does the surgeon identify appropriate candidates for a neoadjuvant regimen, which could include pertuzumab, and refer them to the breast oncologist?